Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interchangeability of MenC-TT and MenC-CRM Booster Vaccines in Toddlers
NCT00392808Phase 4Completed
- Sponsor
- Centro Superior de Investigación en Salud Pública
- Start
- Jan 2007
- Primary completion
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Meningococcal C-CRM conjugate vaccine, meningococcal C-tetanus toxoid conjugate vaccine in Meningococcal disease serogroup C (MenC), sponsored by Centro Superior de Investigación en Salud Pública. Started Jan 2007; status: completed.
02
Drugs
Meningococcal C-CRM conjugate vaccinemeningococcal C-tetanus toxoid conjugate vaccine
03
Conditions
Meningococcal disease serogroup C (MenC)
Beyond the preview
Go deeper on NCT00392808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392808.